| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |